Rachael L Neve

Title: Rachael L Neve: Innovator in Alzheimer's Research

Introduction

Rachael L Neve is a prominent inventor based in Belmont, MA, known for her significant contributions to the field of Alzheimer's research. With a total of three patents to her name, she has made strides in understanding and addressing the complexities of this debilitating disease.

Latest Patents

Rachael's latest patents focus on the cloning and expression of the beta-APP-C100 receptor (C100-R). The present invention relates to the cloning of the beta-APP-C100 receptor and genetically engineered host cells that express the C100-R. Such engineered cells may be utilized to evaluate and screen drugs and analogs of beta-APP involved in Alzheimer's Disease. This innovative approach has the potential to advance therapeutic strategies for those affected by this condition.

Career Highlights

Throughout her career, Rachael has worked with esteemed organizations such as the McLean Hospital Corporation and Bristol-Myers Squibb Company. Her work in these institutions has allowed her to collaborate with leading experts in the field and contribute to groundbreaking research.

Collaborations

Rachael has collaborated with notable colleagues, including Susan P Manly and Michael R Kozlowski. These partnerships have enriched her research and expanded the impact of her inventions.

Conclusion

Rachael L Neve's work exemplifies the innovative spirit necessary to tackle complex health challenges like Alzheimer's Disease. Her patents and collaborations highlight her commitment to advancing medical research and improving patient outcomes.